Echothiophate Iodide

CHEMBL1200367 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
383.2 g/mol
LogP
Phase
4

An iodide salt form of echothiophate used as an eye drop to treat glaucoma by reducing intraocular pressure. It works by inhibiting the enzyme that breaks down acetylcholine in the eye.

Peso Molecular

383,2300 g/mol

TPSA

60,80 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]

InChI

InChI=1S/C9H23NO3PS.HI/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5;/h6-9H2,1-5H3;1H/q+1;/p-1

Molecular Formula

C9H23INO3PS

HBD / HBA

- / 5

Ligações Rotacionáveis

8

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An iodide salt form of echothiophate used as an eye drop to treat glaucoma by reducing intraocular pressure. It works by inhibiting the enzyme that breaks down acetylcholine in the eye.

Yes, Echothiophate Iodide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200367. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10547. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.